#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Spinal cord injury Anti-myelin-associated glycoprotein antibodies positive Hereditary ataxia Li-Fraumeni syndrome Hereditary hypophosphataemic rickets Neutropenia Dementia with Lewy bodies Uterine leiomyosarcoma Vulval cancer recurrent Sickle cell anaemia Plasma cell myeloma refractory B-cell small lymphocytic lymphoma refractory Soft tissue sarcoma Bronchiolitis Neonatal asphyxia More trials…

    Learn about Rare Diseases

    Focal segmental glomerulosclerosis – Life with Disease Paraneoplastic neurological syndrome – Life with Disease Gastrointestinal stromal tumour Hairy cell leukaemia – Treatment Synovial sarcoma recurrent Leiomyosarcoma – Basic Information Lymphangiosarcoma – Life with Disease Hypereosinophilic syndrome – Basic Information Ewing’s sarcoma metastatic – Treatment Langerhans cell sarcoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cinnarizine GXV813 Alnus Glutinosa Pollen MB-CART2219.1 VX-407 ANTI-GD2-800CW Canakinumab Estradiol Valerate Ecoo2 Zolbetuximab Tarlatamab Arachis Hypogaea (762) Iph5201 Ivonescimab 68Ganota-Anti-Her2 Vhh1 Alendronate Sodium Monohydrate Bedaquiline Cefixime Trihydrate ICEF15 Triglycerides, Medium Chain More therapies…

    Learn about Your Condition

    Skin wrinkling Hot flush Left ventricular failure Subdural haematoma Normal pressure hydrocephalus Lumbosacral radiculopathy Penile cancer Dysmenorrhoea Keratosis follicular Abdominal wall pain Monogenic diabetes Delayed graft function Bladder cancer Muscle hypertrophy Placenta praevia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier Intercommunal Toulon / La Seine-Sur-Mer…

Centre Hospitalier Intercommunal Toulon / La Seine-Sur-Mer

54 Rue Henri Sainte Claire Deville, Toulon, 83100, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Chemotherapy and Hormone Therapy for Women Over 70 with ER-Positive, HER2-Negative Breast Cancer Using Cyclophosphamide and Drug Combination

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer female
    Investigated Drugs:
    • Doxorubicin
    • Cyclophosphamide
    • Docetaxel
    Belgium France

  • Study on Aticaprant and Antidepressant for Preventing Relapse in Adults with Major Depressive Disorder and Anhedonia

    Not recruiting

    3 1
    Investigated Diseases:
    • Major depression
    Investigated Drugs:
    • Aticaprant
    Belgium Bulgaria Czechia France Germany Greece +3

  • Study of Niraparib and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Niraparib Tosilate Monohydrate
    • Pembrolizumab
    Belgium Bulgaria France Germany Greece Hungary +8

  • Study on Baxdrostat for Reducing Blood Pressure in Patients with Uncontrolled or Resistant Hypertension

    Not recruiting

    3 1
    Investigated Diseases:
    • Hypertension
    Investigated Drugs:
    • Baxdrostat
    Austria Belgium Bulgaria Czechia Denmark France +8

  • Study on Xevinapant and Radiotherapy for High-Risk Head and Neck Cancer Patients Unable to Take High-Dose Cisplatin

    Not recruiting

    3 1
    Investigated Diseases:
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • Xevinapant
    Austria Belgium Czechia France Germany Greece +6

  • Study of Farletuzumab Ecteribulin for Patients with Metastatic Non-Small Cell Lung Cancer After Previous Treatments

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Farletuzumab Ecteribulin
    France Spain

  • Study on Atezolizumab for Patients with Non-Small Cell Lung Cancer After Chemotherapy

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Atezolizumab
    • Cisplatin
    • Docetaxel
    France Germany Hungary Italy The Netherlands Poland +3

  • Study Comparing Standard Care and Targeted Treatment with Telemonitoring for Ulcerative Colitis Patients Using Adalimumab

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Adalimumab
    France

  • Screening for Hidden Cancer Using FDG PET/CT and Gallium (68Ga) Chloride in Patients Aged 50+ with Unexplained Blood Clots

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Embolism
    • Neoplasm malignant
    Investigated Drugs:
    • Gallium (68Ga) Chloride
    France

  • Study on the Effectiveness and Safety of BAY 3018250 and Low Molecular Weight Heparin for Patients with Proximal Deep Vein Thrombosis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Deep vein thrombosis
    • Thrombolysis
    Investigated Drugs:
    • Bay 3018250
    Belgium Bulgaria Czechia France Germany Greece +5
Previous Page
1 … 4 5 6 7
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!